Angiodynamics (ANGO) Operating Expenses (2010 - 2026)

Angiodynamics (ANGO) has 17 years of Operating Expenses data on file, last reported at $54.4 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 11.47% year-over-year to $54.4 million; the trailing twelve-month figure through Feb 2026 stood at $205.9 million (up 1.6% YoY), and the FY2025 full-year result was $197.7 million, down 50.79% from the prior year.
• Operating Expenses for Q1 2026 stood at $54.4 million, up from $50.9 million in the prior quarter.
• Across five years, Operating Expenses topped out at $242.4 million in Q1 2024 and bottomed at $43.9 million in Q1 2022.
• The 5-year median for Operating Expenses is $52.9 million (2022), against an average of $63.5 million.
• The widest annual swing landed in 2024, when Operating Expenses surged 390.4%; it then plunged 79.86% in 2025.
• A 5-year view of Operating Expenses shows it stood at $53.2 million in 2022, then advanced by 0.36% to $53.4 million in 2023, then declined by 4.46% to $51.0 million in 2024, then slipped by 0.18% to $50.9 million in 2025, then gained by 6.92% to $54.4 million in 2026.
• The last three Operating Expenses figures came in at $54.4 million (Q1 2026), $50.9 million (Q4 2025), and $52.5 million (Q3 2025), per Business Quant data.

Peer Comparison